Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

What's new

This currently recruiting study will support FDA submission of Tandem’s Control-IQ hybrid closed loop for children six years of age or older Continue Reading »

MiniMed 780G, Medtronic, closed loop, artificial pancreas, type 1

This study, now recruiting 350 participants, will examine the safety of the MiniMed 780G Advanced Hybrid Closed Loop System in people with type 1 diabetes (7+ Years) Continue Reading »

DIY Loop virtual study requires no in-person visits and seeks 300-1,000 Loop users, especially those new to Looping. Data will support eventual FDA submission of Tidepool Loop Continue Reading »

The first trial, now recruiting 50 people, is an observational study of insulin requirements and glucose levels using the Dexcom G6 CGM in type 1 pregnancy. Continue Reading »

The study aims to enroll about 1,800 adults with type 2 diabetes at increased risk of heart disease Continue Reading »

time-in-range study diabetes insulin

The SWITCH PRO trial will examine whether Tresiba improves blood sugar management more than Lantus, as measured by FreeStyle Libre Pro; now recruiting at 67 locations across the US Continue Reading »

Ozempic diabetes research trial

A trial is enrolling over 2,000 people in any Anthem health plan with type 2 diabetes Continue Reading »

diabetes kids adolescents

A study is enrolling over 100 people with type 2 between the ages of 10 and 18 years, examining Jardiance and Tradjenta Continue Reading »

Pages